BIOCEPT, INC. — Revenue by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/b8cbb7ff-b1d7-4da6-ac97-228ee5cfdafe/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2022 | $25.9M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-013109 |
| FY 2021 | $61.2M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-013599 |
| FY 2020 | $27.5M | 2020-01-01 – 2020-12-31 | evidence 0001564590-22-013599 |
| FY 2019 | $5.5M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-013670 |
| FY 2018 | $3.3M | 2018-01-01 – 2018-12-31 | evidence 0001564590-20-013670 |
| FY 2017 | $5.1M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-006985 |
| FY 2016 | $3.2M | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-005382 |
| FY 2015 | $609.9k | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-014436 |
| FY 2014 | $133.4k | 2014-01-01 – 2014-12-31 | evidence 0001564590-15-001482 |
| FY 2013 | $134.2k | 2013-01-01 – 2013-12-31 | evidence 0001564590-15-001482 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).